Wyeth Replaces Dosing Measure For Pediatric Dimetapp, Robitussin Products
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Consumer Healthcare is voluntarily recalling and replacing Children's Dimetapp Cold & Chest Congestion and multiple products in its Robitussin line because the products' dosing cups are not marked with half-teaspoon units, the recommended dose for children ages 2 to 6, the firm said Oct. 29
You may also be interested in...
Wyeth’s International OTC Growth Offsets Drop In U.S. Robitussin Sales
Sales of Wyeth's OTC products increased 10.4 percent worldwide in its fiscal 2008 first quarter despite a 14.2 percent drop in sales of its Robitussin cough/cold products, the firm says
Wyeth’s International OTC Growth Offsets Drop In U.S. Robitussin Sales
Sales of Wyeth's OTC products increased 10.4 percent worldwide in its fiscal 2008 first quarter despite a 14.2 percent drop in sales of its Robitussin cough/cold products, the firm says
Wyeth’s International OTC Growth Offsets Drop In U.S. Robitussin Sales
Sales of Wyeth's OTC products increased 10.4 percent worldwide in its fiscal 2008 first quarter despite a 14.2 percent drop in sales of its Robitussin cough/cold products, the firm says